Danoprevir
- Generic Name
- Danoprevir
- Drug Type
- Small Molecule
- Chemical Formula
- C35H46FN5O9S
- CAS Number
- 850876-88-9
- Unique Ingredient Identifier
- 911Z9PCQ5F
Overview
Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
Background
Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
Indication
本品应与利托那韦、聚乙二醇干扰素α和利巴韦林联合组成抗病毒治疗方案，用于治疗初治的非肝硬化的基因1b型慢性丙型肝炎成人患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath